Identification | Back Directory | [Name]
LUPENONE | [CAS]
1617-70-5 | [Synonyms]
LUPENONE -en-3-one Lup-20(29) Aids082905 Aids-082905 LUPENONE(RG) 18-LUPEN-3-ONE Lup-20(29)-en-3-one Lupa-20(30)-ene-3-one Lupa-20(29)-ene-3β-one 5α-Lup-20(29)-en-3-one (1R,3Ar,4S,5ar,5br,7ar,11ar,11br,13ar,13br)-1-isopropenyl-3A,5A,5B,8,8,11A-hexamethyl-eicosahydro-cyclopenta[A]chrysen-9-one (1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysen-9-one | [Molecular Formula]
C30H48O | [MDL Number]
MFCD00083578 | [MOL File]
1617-70-5.mol | [Molecular Weight]
424.7 |
Chemical Properties | Back Directory | [Melting point ]
165-167°C | [Boiling point ]
485.7±14.0 °C(Predicted) | [density ]
1.115 g/cm3(Temp: 18 °C) | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White | [LogP]
10.400 (est) |
Hazard Information | Back Directory | [Uses]
Lupenone is a lupane triterpenoid with antioxidant and anticholinesterase activity. It also a potential protein tyrosine phosphatase 1B (PTP1B) inhibitor. | [Definition]
ChEBI: A natural product found in Cupania cinerea. | [in vivo]
Lupenone (6, 12, 24 mg/kg/day, gavage for 6 weeks) improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/ CTGF-related fibrosis[2].
Animal Model: | Spontaneous type 2 diabetic nephropathy db/db mouse models[1] | Dosage: | 6, 12, 24 mg/kg | Administration: | i.g. | Result: | Maintained the fasting blood glucose.
Reduced glycosylated hemoglobin, insulin, and 24 h proteinuria levels.
Regulated changes in biochemical indicators
|
| [IC 50]
Trypanosoma | [storage]
4°C, protect from light |
|
|